Weber, Michael; Lupp, Corinna; Stein, Pamela et al.
Mechanisms of Cyclic Nucleotide Phosphodiesterases in Modulating T Cell Responses in Murine Graft-versus-Host DiseasePLoS one. Bd. 8. H. 3. Lawrence, Kan.: PLoS 2013 e58110
Bosmann, Markus; Ward, Peter A.
Modulation of inflammation by interleukin-27JOURNAL OF LEUKOCYTE BIOLOGY. Bd. 94. H. 6. 2013 S. 1159-1165
Landfester, Katharina; Mailaender, Volker
Nanocapsules with specific targeting and release properties using miniemulsion polymerizationEXPERT OPINION ON DRUG DELIVERY. Bd. 10. H. 5. 2013 S. 593-609
Wagner, Meike; Koslowski, Michael; Paret, Claudia et al.
NCOA3 is a selective co-activator of estrogen receptor alpha-mediated transactivation of PLAC1 in MCF-7 breast cancer cellsBMC CANCER. Bd. 13. 2013
Hartwell, Kimberly A.; Miller, Peter G.; Mukherjee, Siddhartha et al.
Niche-based screening identifies small-molecule inhibitors of leukemia stem cellsNATURE CHEMICAL BIOLOGY. Bd. 9. H. 12. 2013 S. 840-+
Scheer, M.; Dopheide, J.; Obst, V. et al.
Patients with peripheral arterial Occlusive Disease (paOD) show an attenuated Proinflammation after 11 Months of unstructured approach TrainingINTERNIST. Bd. 54. H. 6. 2013 S. 745-746
Kroeller-Schoen, Swenja; Jansen, Thomas; Schueler, Andrea et al.
Peroxisome Proliferator-activated Receptor , Coactivator 1 Deletion Induces Angiotensin II-Associated Vascular Dysfunction by Increasing Mitochondrial Oxidative Stress and Vascular InflammationARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Bd. 33. H. 8. 2013 S. 1928-1935
Schulz, Eberhard; Kroeller-Schoen, Swenja; Jansen, Thomas et al.
PGC-1 alpha deletion accelerates angiotensin II induced endothelial dysfunction by increasing mitochondrial oxidative stress and vascular agingFASEB JOURNAL. Bd. 27. 2013
Hofmann, Daniel; Mailaender, Volker
Pharmacology of nanocarriers on the microscale: importance of uptake mechanisms and intracellular trafficking for efficient drug deliveryNANOMEDICINE. Bd. 8. H. 3. 2013 S. 321-323
DeAngelo, D. J.; Spencer, A.; Bhalla, K. N. et al.
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignanciesLEUKEMIA. Bd. 27. H. 8. 2013 S. 1628-1636